Before We Start
Four mechanisms, so resistance can't develop to all of them at once
TB treatment isn't front-loaded with four drugs out of excessive caution — it's a direct response to how easily M. tuberculosis can develop resistance over the many months treatment actually takes.
💡 Memory Trick
RIPE: Rifampin · Isoniazid · Pyrazinamide · Ethambutol — first 2 months of TB treatment. Four distinct mechanisms make simultaneous resistance to the whole regimen far less likely than resistance to any one drug alone.
The Key Points
Four drugs, four mechanisms, four distinct side effects to monitor
R
Rifampin — inhibits RNA polymerase, and induces drug metabolism broadly
Rifampin inhibits bacterial RNA polymerase. Notably, it turns body fluids (urine, tears) a red-orange color — a harmless but important thing to warn patients about in advance — and it's a potent inducer of cytochrome P450 enzymes, which can significantly affect the metabolism of many other medications a patient might be taking.
🦠 A patient on rifampin taking other medications metabolized through the same cytochrome P450 pathways may need those other drug doses adjusted, since rifampin actively speeds up their breakdown.
I
Isoniazid — needs B6 supplementation to prevent a specific side effect
Isoniazid (INH) inhibits mycolic acid synthesis, a component specific to the mycobacterial cell wall. It requires supplementation with vitamin B6 (pyridoxine) to prevent peripheral neuropathy, a common and avoidable side effect if B6 is given alongside it from the start.
🦠 A patient started on isoniazid without B6 supplementation develops tingling and numbness in the feet several weeks into treatment — peripheral neuropathy, a preventable side effect that pyridoxine supplementation from the start would have avoided.
P
Pyrazinamide — uniquely active in acidic environments
Pyrazinamide is uniquely active in the acidic environment found inside macrophages, where dormant or slow-growing mycobacteria often hide. It can cause hyperuricemia as a side effect.
🦠 Pyrazinamide's specific ability to work in the acidic macrophage environment lets it reach mycobacteria that other drugs in the regimen might not effectively target in that same location.
E
Ethambutol — requires monitoring for optic neuritis
Ethambutol inhibits arabinogalactan synthesis, another component of the mycobacterial cell wall. It requires monitoring for optic neuritis, which can present as changes in color vision — patients should be counseled to report any visual changes immediately.
🦠 A patient on ethambutol who notices any change in how colors appear should report it immediately, since early detection of optic neuritis can prevent more serious, potentially permanent visual damage.
🏥 Applied Scenario
A patient is diagnosed with active tuberculosis and started on the standard four-drug intensive-phase regimen: Rifampin, Isoniazid, Pyrazinamide, and Ethambutol, and a colleague asks why four drugs are needed at once.
Step 1
Explain why four drugs are necessary: M. tuberculosis mutates frequently enough that any two-drug combination would eventually select for resistant mutants during the many months of treatment TB requires — four drugs, each with a different mechanism, make it far less likely the organism can develop resistance to the entire regimen simultaneously.
Step 2
Describe how the regimen changes over time: After two months of this intensive four-drug phase, treatment simplifies to just Rifampin and Isoniazid for four more months — by that point, the bacterial burden has been substantially reduced, lowering the risk that resistant mutants will emerge even with fewer drugs.
Step 3
Recognize why this structure specifically applies to TB: Most bacterial infections don't require this level of multi-drug protection because they're treated for much shorter durations — TB's unusually long treatment course is exactly what creates the extended opportunity for resistance to develop that this regimen is designed to prevent.
Step 4
Conclusion: The four-drug intensive phase and the later two-drug continuation phase both reflect the same underlying logic — matching drug intensity to the actual resistance risk at each stage of a long treatment course.
📌 Exam Application
Exams test the full RIPE regimen (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) and its overall structure (2 months intensive four-drug phase, then 4 months of Rifampin + Isoniazid), why four drugs are needed (M. tuberculosis's high mutation rate), and the distinctive side effect of each individual drug — Rifampin's red-orange fluids and CYP450 induction, Isoniazid's peripheral neuropathy (preventable with B6), Pyrazinamide's hyperuricemia, and Ethambutol's optic neuritis.
⚠️ The Trap — Assuming a Shorter or Simpler Regimen Would Be Adequate
The most common trap is assuming a shorter or simpler drug regimen would be adequate for TB the way it might be for many other bacterial infections. M. tuberculosis's unusually high mutation rate specifically requires the four-drug intensive phase — using fewer drugs risks selecting for resistant organisms during the many months treatment takes, a risk that doesn't apply the same way to shorter-course infections.
✓ Quick Self-Test
Answer before checking:
1. What does RIPE stand for?
2. What is the overall structure of standard TB treatment?
3. Why does TB treatment require four drugs initially, rather than one or two?
4. What supplement should be given alongside isoniazid, and why?
5. What side effect is associated with ethambutol, and what should patients be counseled to watch for?
Answers:
1. Rifampin, Isoniazid, Pyrazinamide, Ethambutol.
2. Two months of all four RIPE drugs (intensive phase), followed by four more months of Rifampin plus Isoniazid alone.
3. Because M. tuberculosis mutates frequently, and any two-drug combination would eventually select for resistant mutants over the many months treatment requires.
4. Vitamin B6 (pyridoxine), to prevent peripheral neuropathy.
5. Optic neuritis; patients should report any changes in color vision or other visual changes immediately.